Heather Platter | Health Professions | Innovative Research Award

Published on by Academic Achievements

Innovative Research Award

Heather Platter
Affiliation University of Virginia, School of Medicine, Public Health Sciences
Country United States
Scopus ID 57192999339
Documents 7
Citations 100
h-index 5
Subject Area Health Professions
Event International Academic Achievements & Awards

Heather Platter
University of Virginia, School of Medicine, Public Health Sciences,
United States

Heather Platter, is a public health scientist and academic researcher whose work centers on cancer prevention, health literacy, behavioral health communication, health decision-making, and cancer survivorship research. Currently serving as Assistant Professor in the Department of Public Health Sciences at the University of Virginia School of Medicine, Dr. Platter has developed an interdisciplinary research portfolio that integrates qualitative methods, behavioral science, health communication frameworks, and implementation research to improve public health outcomes.[1]

Abstract

Heather Platter, is a public health researcher specializing in cancer prevention, health literacy, behavioral science, and health communication. Her academic work focuses on improving informed decision-making, reducing health misinformation, and enhancing communication strategies related to cancer screening, survivorship, and public health interventions. Through interdisciplinary research integrating qualitative and quantitative methodologies, she has contributed to advancing evidence-based health communication practices. Her scholarly achievements, leadership roles, funded research initiatives,and mentorship activities demonstrate an ongoing commitment to improving population health outcomes and strengthening public health systems.[2]

Keywords

Public Health • Cancer Prevention • Health Literacy • Behavioral Science • Cancer Communication • Risk Communication • Cancer Survivorship • Mixed Methods Research • Health Decision-Making • Tobacco Control • Community Health • Health Misinformation

Introduction

Platter completed undergraduate and graduate training at the University of Florida before earning a Doctor of Philosophy in Behavioral and Community Health from the University of Maryland. Additional graduate certificates in Global Health, Social and Behavioral Public Health, and Non-Profit Management strengthened her interdisciplinary academic foundation.[1]

Her postdoctoral fellowship at the National Cancer Institute contributed significantly to her expertise in behavioral research, cancer prevention, and public communication strategies. She later joined the University of Virginia School of Medicine as Assistant Professor, continuing work at the intersection of communication science and population health.[3]

Research Profile

  • Cancer prevention communication research
  • Health literacy assessment and intervention science
  • Behavioral public health
  • Cancer screening communication
  • Risk visualization methodologies
  • Health misinformation mitigation strategies
  • Qualitative and mixed-methods research
  • Patient-provider communication studies

Research Contributions

Platter has contributed to understanding health literacy challenges and communication barriers affecting informed health decisions. Her studies examining health insurance literacy among cancer survivors have expanded understanding of decision-making complexities experienced by patients navigating cancer treatment systems.[4]

Her work investigating cancer screening information-seeking behaviors before and during the COVID-19 pandemic contributed evidence regarding communication adaptation during public health emergencies.[5]

Research involving health misinformation interventions explored psychological inoculation and self-affirmation approaches for improving public resilience against misleading health information.

Publications

Heather Platter’s publication record reflects significant contributions to public health communication, cancer prevention, health literacy, and behavioral science. Her peer-reviewed research addresses cancer survivorship, health misinformation, screening communication, and patient decision-making. Through interdisciplinary scholarship published in respected journals, her work advances evidence-based approaches to improving health communication strategies and public health outcomes.

Research Impact

Platter’s work demonstrates sustained influence across cancer prevention, health communication, and literacy research. Citation activity reported within her academic record reflects uptake of her work by scholars investigating behavioral science, communication frameworks, and preventive medicine. Leadership appointments within the National Cancer Institute and mentoring activities further indicate broader contributions beyond publication output.

Award Suitability

Heather Platter demonstrates characteristics commonly associated with academic recognition in public health sciences, including sustained scholarly productivity, interdisciplinary research development, mentorship contributions, leadership service, funded research participation, and innovation in communication science. Her work connecting health literacy and cancer prevention supports broader public health objectives aimed at improving informed decision-making and health equity.

Conclusion

Heather Platter has developed a research portfolio positioned at the intersection of behavioral science, communication, and cancer prevention. Through scholarly publications, mentorship, leadership activities, and translational health communication research, her contributions reflect ongoing efforts to improve evidence-based public health practice and cancer prevention communication systems.[1]

References

  1. Platter, H. N., Vanderpool, R. C., Davidoff, A. J., de Moor, J. S., & Williams, C. P. (2025). Understanding cancer survivor cost communication experiences and preferences. Supportive Care in Cancer, 33, 450. https://doi.org/10.1007/s00520-025-09506-6
  2. Williams, C., Platter, H., Davidoff, A., Vanderpool, R., Pisu, M., & de Moor, J. (2023). “It’s just not easy to understand”: Health insurance literacy and insurance plan decision-making in cancer survivors. Cancer Medicine, 12(14), 15424–15434. https://doi.org/10.1002/cam4.6133
  3. Seidenberg, A. B., Wiseman, K. P., Eck, R. H., Blake, K. D., Platter, H., & Klein, W. M. P. (2022). Alcohol consumption, awareness of alcohol as a carcinogen, and support for alcohol control policies. American Journal of Preventive Medicine, 62(2), 174–182. https://doi.org/10.1016/j.amepre.2021.07.005
  4. Iles, I. A., Gillman, A. S., Platter, H., Ferrer, R. A., & Klein, W. M. P. (2021). Investigating the potential of inoculation messages and self-affirmation in reducing the effects of health science misinformation. Science Communication, 43(6), 768–804. https://doi.org/10.1177/10755470211048480
  5. Platter, H., & Pokorny, S. (2017). Smoke-free signage in public parks: Impacts on smoking behaviour. Tobacco Control, 27(4), 470–473. https://doi.org/10.1136/tobaccocontrol-2016-053624

Ji Young Yoon | Medicine and Dentistry | Research Excellence Award

Published on by Academic Achievements

Research Excellence Award

Ji Young Yoon
Assistant Professor, Department of Orthopaedic Surgery, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, South Korea

Ji Young Yoon
Affiliation Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, South Korea
Country South Korea
Scopus ID 59046754400
Documents 1
Citations 6
h-index 1
Subject Area Medicine and Dentistry
Event International Academic Achievements & Awards

Dr. Ji Young Yoon is an orthopaedic surgeon and academic researcher specializing in shoulder surgery, arthroscopy, sports medicine, and rotator cuff pathology. As an Assistant Professor at Eulji University School of Medicine, Dr. Yoon has contributed extensively to clinical orthopaedic research through multicenter studies, randomized clinical trials, and translational surgical investigations focused on improving patient outcomes and rehabilitation strategies.[1]

Abstract

Dr. Ji Young Yoon has established a distinguished academic and clinical profile in orthopaedic surgery with research emphasizing arthroscopic shoulder procedures, rotator cuff repair, reverse shoulder arthroplasty, and postoperative rehabilitation. Through collaborative clinical investigations and evidence-based surgical studies, Dr. Yoon has contributed to advancing modern orthopaedic treatment methodologies, surgical optimization, and patient-centered musculoskeletal care.[2]

Keywords

Orthopaedic Surgery, Arthroscopy, Rotator Cuff Repair, Reverse Shoulder Arthroplasty, Sports Medicine, Shoulder Surgery, Rehabilitation, Musculoskeletal Research, Arthroscopic Surgery, Clinical Orthopaedics

Introduction

The field of orthopaedic surgery continues to evolve through advancements in minimally invasive procedures, biologic augmentation, and rehabilitation sciences. Dr. Ji Young Yoon has actively participated in these developments through clinical research and academic leadership in shoulder and sports medicine. His work integrates surgical precision with evidence-based postoperative management strategies to improve functional recovery and long-term patient outcomes.[3]

Research Profile

Dr. Yoon serves as Assistant Professor at Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, South Korea. He is an active member of the Korean Orthopaedic Association, Korean Shoulder and Elbow Society, Korean Arthroscopy Society, and APKASS. Additionally, he contributes to the academic community as a reviewer for several international journals including the Journal of Shoulder and Elbow Surgery, Clinics in Orthopedic Surgery, and AP-SMART.[4]

  • Specialization in shoulder and elbow surgery
  • Clinical expertise in arthroscopic reconstruction techniques
  • Research focus on rotator cuff healing and rehabilitation
  • Reviewer for international orthopaedic journals
  • Member of the 2026 APKASS Organizing Committee

Research Contributions

Dr. Yoon’s research contributions encompass prospective randomized trials, multicenter studies, imaging-based diagnostics, biologic therapies, and arthroscopic innovations. His investigations into rotator cuff repair, postoperative pain management, dermal fibroblast injection therapy, and reverse shoulder arthroplasty have contributed to contemporary orthopaedic surgical practices.[5]

  • Development of clinical protocols for arthroscopic shoulder surgery
  • Research on tendon-to-bone healing enhancement strategies
  • Evaluation of MRI predictors in shoulder stiffness and rotator cuff tears
  • Studies on biologic augmentation and dermal allograft applications
  • Clinical evaluation of reverse total shoulder arthroplasty outcomes

Publications

Dr. Ji Young Yoon has authored and co-authored numerous peer-reviewed publications in orthopaedic surgery and sports medicine. His scholarly work focuses on shoulder arthroscopy, rotator cuff repair, reverse shoulder arthroplasty, rehabilitation protocols, biologic augmentation, and postoperative outcomes, contributing significantly to evidence-based musculoskeletal surgery and clinical orthopaedic advancement worldwide.[5]

Research Impact

The clinical significance of Dr. Yoon’s work is reflected in his contributions to surgical optimization, patient rehabilitation, and translational orthopaedic research. His investigations have supported improved understanding of tendon healing, arthroscopic outcomes, biologic interventions, and shoulder biomechanics, thereby strengthening evidence-based surgical practice in orthopaedics.

Award Suitability

Dr. Ji Young Yoon demonstrates strong suitability for international academic recognition due to his sustained contributions to orthopaedic surgery research, clinical innovation, scientific publishing, and professional leadership. His receipt of multiple Korean Orthopaedic Association Best Poster Awards and national commendation certificates further reflects academic excellence, clinical dedication, and impactful research engagement.

Conclusion

Dr. Ji Young Yoon has established a respected academic and clinical presence within the field of orthopaedic surgery through his multidisciplinary research, evidence-based surgical investigations, and scholarly collaborations. His work continues to support advancements in shoulder surgery, sports medicine, and musculoskeletal rehabilitation while contributing to the broader international orthopaedic research community.

References

  1. American Journal of Sports Medicine. (2012). Clinical comparison of conventional and remnant-preserving transtibial single-bundle posterior cruciate ligament reconstruction.https://journals.sagepub.com/home/ajs
  2. Journal of Shoulder and Elbow Surgery. (2020). Effect of tranexamic acid on blood loss after reverse total shoulder arthroplasty.https://doi.org/10.1016/j.jse.2020.01.091
  3. The Korean Journal of Pain. (2020). Far-infrared radiation and tendon-to-bone healing after arthroscopic rotator cuff repair.https://www.epain.org/
  4. Journal of Shoulder and Elbow Surgery International. (2023). Predictive MRI findings of rotator cuff tear concomitant with shoulder stiffness.https://www.jsesinternational.org/
  5. Orthopaedic Journal of Sports Medicine. (2021). Safety and efficacy of autologous dermal fibroblast injection after rotator cuff repair.https://journals.sagepub.com/home/ojs

Jana Wattar | Pharmacology | Women Researcher Award

Published on by Academic Achievements

Women Researcher Award

Jana K. Al Wattar
Lebanese International University,  Lebanon
Jana K. Al Wattar
Affiliation Lebanese International University
Country Lebanon
Scopus ID 56999102300
Documents 9
Citations 172
h-index 5
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Academic Achievements & Awards

Jana K. Al Wattar is a Lebanese pharmaceutical scientist, academic researcher, and Assistant Professor specializing in pharmaceutical sciences, nanotechnology-based drug delivery systems, and translational nanomedicine. Her research primarily focuses on smart lipid-based nanocarriers for cancer therapeutics and neurodegenerative disorders, with emphasis on enhancing therapeutic efficacy, improving drug bioavailability, and overcoming multidrug resistance mechanisms.[1]

Over more than a decade of academic and professional engagement, Dr. Al Wattar has contributed extensively to pharmaceutical education, interdisciplinary nanomedicine research, and international scientific collaboration. Her work integrates pharmaceutical technology, nanotechnology, biotechnology, and biomedical innovation through collaborative partnerships across Lebanon, the Gulf region, and international academic institutions.[2]

Abstract

Jana K. Al Wattar has established a distinguished research profile in pharmaceutical sciences with specialization in nanotechnology-based therapeutic delivery systems for oncology and neurological disorders. Her scientific contributions encompass the formulation, optimization, and characterization of smart nanocarriers, including nanovesicles, nanosponge systems, liposomal nanohybrids, electrohydrodynamic nanofibers, and stimuli-responsive drug delivery platforms.[3]

Her work demonstrates interdisciplinary integration of pharmaceutical technology, nanomedicine, biomaterials, and translational therapeutics. In addition to publishing in internationally recognized journals, she has actively contributed to scientific conferences, secured competitive research grants, supervised collaborative projects, and established institutional research partnerships across the Middle East and beyond.[4]

Keywords

Nanomedicine; Pharmaceutical Technology; Drug Delivery Systems; Lipid Nanocarriers; Cancer Therapeutics; Neurodegenerative Disorders; Smart Nanovesicles; Nanotechnology; Biomaterials; Pharmaceutical Biotechnology; Liposomal Systems; Targeted Drug Delivery; Tissue Engineering; Translational Medicine; Pharmaceutical Sciences

Introduction

Advances in nanotechnology and pharmaceutical sciences have transformed the development of targeted therapeutic systems for complex diseases including cancer and neurodegenerative disorders. Researchers in pharmaceutical nanotechnology contribute significantly to improving therapeutic outcomes through innovative drug delivery systems that enhance bioavailability, stability, specificity, and patient safety. Dr. Jana K. Al Wattar has contributed to this evolving field through sustained academic research focused on nanocarrier engineering, smart drug delivery systems, and translational pharmaceutical applications.[5]

Her research vision aims to establish a translational nanomedicine platform in the Levant region that addresses unmet therapeutic challenges associated with drug resistance, poor bioavailability, and targeted treatment delivery. Her academic and scientific activities demonstrate commitment to regional research development, scientific leadership, and interdisciplinary collaboration.

Research Profile

Dr. Al Wattar currently serves as a Full-time Assistant Professor in the Department of Pharmaceutical Sciences at Lebanese International University in Beirut, Lebanon. Her teaching portfolio includes pharmaceutics, dosage forms, pharmaceutical calculations, physical pharmacy, compounding laboratories, biotechnology laboratories, and pharmacy practice experience courses.

Her academic experience spans more than twelve years in higher education, during which she has contributed to undergraduate and postgraduate mentorship, pharmaceutical curriculum development, and scientific supervision. Prior to her current appointment, she served as Lecturer Assistant at Beirut Arab University and Instructor at Lebanese International University.

Her doctoral studies in Pharmaceutical Technology and Industrial Pharmacy at Beirut Arab University focused on innovative nanotechnology-based formulations and advanced pharmaceutical delivery systems. Her academic trajectory has consistently emphasized pharmaceutical innovation and translational therapeutic applications.

Research Contributions

Dr. Al Wattar has contributed substantially to nanomedicine research through development and optimization of advanced drug delivery systems. Her investigations focus on enhancing therapeutic efficacy while minimizing toxicity through rational nanocarrier design and smart pharmaceutical engineering strategies.

  • Development of lipid-based nanocarriers for targeted cancer therapeutics.
  • Optimization of nanovesicle systems for neurological and neuroinflammatory disorders.
  • Investigation of smart stimuli-responsive liposomal nanohybrid systems for theranostic applications.
  • Research on electrohydrodynamic atomization for fast-dissolving drug delivery systems.
  • Studies involving thymoquinone-loaded nanosystems for oxidative stress modulation and anticancer activity.
  • Collaborative interdisciplinary projects involving biomaterials, tissue engineering, and pharmaceutical biotechnology.

Her collaborative network extends across leading institutions in Lebanon, the United Arab Emirates, Jordan, and Egypt, demonstrating active international scientific engagement in pharmaceutical nanotechnology and translational biomedical sciences.

Publications

Jana K. Al Wattar has authored and co-authored numerous peer-reviewed publications in pharmaceutical sciences, nanomedicine, and drug delivery research. Her scholarly work focuses on lipid nanovesicles, smart nanocarriers, cancer therapeutics, neurodegenerative disorders, and pharmaceutical biotechnology, contributing to advancements in targeted drug delivery systems and translational pharmaceutical innovation.

Research Impact

Dr. Al Wattar’s research contributes to advancing pharmaceutical nanotechnology and translational medicine in the Middle East region. Her work on smart nanocarrier systems addresses critical biomedical challenges related to targeted therapy, controlled drug release, and therapeutic optimization.

Her scholarly contributions have been recognized through multiple academic distinctions, including research grants, best oral presentation awards, poster awards, and competitive doctoral scholarships. These recognitions reflect sustained engagement in innovative pharmaceutical research and academic leadership.

Beyond publications, her impact is evident in scientific mentorship, supervision of institutional collaborations, and active involvement in regional capacity-building initiatives related to pharmaceutical sciences and biomedical innovation.

Award Suitability

Dr. Jana K. Al Wattar demonstrates qualifications aligned with the criteria of an Outstanding Researcher Award through her interdisciplinary scientific contributions, international collaborations, research leadership, and commitment to pharmaceutical innovation.

  • Extensive expertise in nanotechnology-based drug delivery systems.
  • Strong publication profile in pharmaceutical and nanomedicine journals.
  • Leadership in regional and international collaborative research initiatives.
  • Successful acquisition of competitive research grants and academic awards.
  • Long-standing commitment to pharmaceutical education, mentorship, and scientific capacity building.

Conclusion

Dr. Jana K. Al Wattar represents a significant emerging voice in pharmaceutical nanotechnology and translational drug delivery research. Her academic profile combines innovative scientific investigation, interdisciplinary collaboration, educational leadership, and regional research development. Through sustained contributions to nanomedicine, targeted therapeutics, and pharmaceutical sciences, she continues to strengthen scientific advancement within the Levant region and the broader international biomedical research community.

References

  1. Lebanese International University. (2026). Faculty profile of Dr. Jana K. Al Wattar.
  2. Beirut Arab University. (2025). Academic and research activities in pharmaceutical sciences.
  3. Alwattar, J.K., et al. (2021). Smart stimuli-responsive liposomal nanohybrid systems: A critical review of theranostic behavior in cancer. Pharmaceutics.
  4. AAU Health & Biomedical Symposium. (2024). Conference awards and scientific participation records.
  5. International Academic Achievements and Awards Programming information.                          International Academic Achievements & Awards

Xinge Du | Architectural Design and Theory | Research Excellence Award

Published on by Academic Achievements

Dr. Xinge Du | Architectural Design and Theory | Research Excellence Award

Tianjin University | China

Dr. Xinge Du (Dylan) is a Ph.D. candidate in Architecture at Tianjin University, specializing in green building, low-carbon campus planning, and building performance optimization. His research integrates sustainable design principles with advanced simulation and BIM technologies to develop practical solutions for energy-efficient built environments. He previously earned his Master’s and Bachelor’s degrees from Taiyuan University of Technology, where he received multiple academic scholarships and honors. Du has published in high-impact journals such as Scientific Reports and Sustainability, contributing innovative frameworks for low-carbon building retrofits and campus design. Actively involved in industry-linked projects, he has led architectural designs incorporating photovoltaic systems and passive energy strategies. His award-winning work in rural housing and campus retrofitting demonstrates a strong commitment to sustainable development and real-world architectural innovation.

Citation Metrics (Scopus)

9

6

3

0

Citations
6

Documents
2

h-index
2

🟦 Citations 🟥 Documents 🟩 h-index

Featured Publications

 

 

Annamaria Pratelli | Veterinary Medicine | Research Excellence Award

Published on by Academic Achievements

Prof. Dr. Annamaria Pratelli | Veterinary Medicine | Research Excellence Award

Università degli Studi di Bari – Dipartimento di Medicina Veterinaria | Italy

Prof. Annamaria Pratelli is a Full Professor of Infectious Diseases of Animals at the University of Bari, Italy, and a globally recognized expert in veterinary virology and coronavirus research. She has been listed among the World’s Top 2% Scientists by Stanford University (2022 and 2025) and has contributed significantly to the study of animal coronaviruses and zoonotic diseases. With over 205 peer-reviewed publications, an H-index of 33, and more than 3,100 citations (Scopus, 2026), her work spans viral pathogenesis, epidemiology, and antiviral strategies. She has led multiple nationally funded research projects and actively contributed to SARS-related task forces in collaboration with national health authorities. Prof. Pratelli serves on several international editorial boards and has extensive experience in scientific evaluation and governance, with impactful contributions to One Health and global infectious disease research.

Citation Metrics (Scopus)

3500

2500

1500

500

0

Citations
3,125

Documents
123

h-index
34

🟦 Citations 🟥 Documents 🟩 h-index

Featured Publications

Evidence for evolution of canine parvovirus type 2 in Italy
– Journal of General Virology (2001) | Citations: 854

A canine parvovirus mutant is spreading in Italy
– Journal of Clinical Microbiology (2004) | Citations: 180

Genetic diversity of a canine coronavirus detected in pups with diarrhoea in Italy
– Journal of Virological Methods (2003) | Citations: 155

Development of a nested PCR assay for the detection of canine coronavirus
– Journal of Virological Methods (1999) | Citations: 135

 

Mohammad Kamil | Pharmaceutical Science | Distinguished Scientist Award

Published on by Academic Achievements

Professor Dr. Mohammad Kamil | Pharmaceutical Science | Distinguished Scientist Award

Lotus Holistic Health Institute | United Arab Emirates

Prof. Dr. Mohammad Kamil, M.Sc., M.Phil., Ph.D., D.Sc., C.Chem., F.R.S.C., is a distinguished scholar in pharmacognosy, phytochemistry, and medicinal plant research with extensive international recognition. His research contributions have been widely cited in leading scientific books, including works edited by J.B. Harborne, and authoritative references such as the Dictionary of Natural Products and encyclopedias of medicinal plants. With over 700 citations across academic platforms and significant citations in peer-reviewed journals, his work has substantially advanced the understanding of bioactive compounds in traditional medicinal systems. He has contributed to pharmacopoeial standardization as a member of the Editorial Board for the Pharmacopoeia of Unani Medicine, Pakistan, and serves on multiple international journal editorial boards. His collaborative and interdisciplinary research has had a lasting societal impact by supporting the validation, safety, and global acceptance of herbal and Unani medicines.

Citation Metrics (Scopus)

600

400

200

0

Citations
563

Documents
19

h-index
8

🟦 Citations 🟥 Documents 🟩 h-index

Featured Publications

 

 

Aishwarya R Kurdekar | Pharmaceutical Science | Best Researcher Award

Published on by Academic Achievements

Ms. Aishwarya R Kurdekar |  Pharmaceutical Science | Best Researcher Award

Bapuji pharmacy college | India
Ms. Aishwarya R. Kurdekar is a dedicated Pharmacology Research Scholar at Bapuji Pharmacy College, specializing in anticancer pharmacology, natural product drug discovery, and oxidative stress mechanisms. She holds an M.Pharm in Pharmacology and has contributed to advancing plant-based therapeutic research through both experimental and computational approaches. Her notable publication in Cell and Tissue Biology (Springer Nature) explores the antioxidant and anticancer potential of Argemone mexicana seed extract using HepG2 liver cancer cell lines. Her research integrates in-vitro studies with LC-MS profiling, network pharmacology, and molecular docking to identify bioactive compounds and molecular targets. She has actively collaborated with academic researchers and presented her work at national conferences, earning recognition including a Best E-Poster Award. Her ongoing research focuses on pancreatic cancer (PANC-1) cell lines, aiming to develop safer, effective anticancer strategies with societal impact.

Featured Publications

 

Chien-Lung Hsu | Healthcare | Best Researcher Award

Published on by Academic Achievements

Prof. Chien-Lung Hsu | Healthcare | Best Researcher Award

Professor at Chang-Gung University (CGU), Taiwan.

Dr. Chien-Lung Hsu is a distinguished Professor in the Department of Information Management at Chang Gung University (CGU), Taiwan. Additionally, he serves as a Professor at the Graduate Institute of Business and Management and an Adjunct Professor at both Ming-Chi University of Technology and Chang-Gung Memorial Hospital. He received his Ph.D. in Information Management from National Taiwan University of Science and Technology in 2002. Dr. Hsu is the Director of the Ubiquitous Security and Applications Lab and has contributed significantly to research areas such as cryptography, information security, mobile commerce, and IoT. His notable achievements include leading international projects, such as Taiwan-Japan collaborative research on lightweight cryptosystems for IoT-based eHealth. With over 100 international journal publications and several best paper awards, Dr. Hsu is highly regarded in his field. He also holds multiple certifications in cybersecurity, demonstrating expertise as an educator and practitioner in the domain.

Profile Verification

Scopus 

Education

Dr. Chien-Lung Hsu holds a Ph.D. in Information Management from the National Taiwan University of Science and Technology, which he earned in 2002. He also completed an M.S. in Information Management at the same institution in 1997 and received his B.S. in Business Administration in 1995. Dr. Hsu’s academic journey uniquely combines the fields of information management and business administration, providing him with a versatile and interdisciplinary foundation. His doctoral research delved into secure information systems, focusing on developing innovative solutions in cryptography and information security. This work laid the groundwork for his prolific academic and professional career, where he has contributed significantly to advancements in cybersecurity, mobile commerce, digital forensics, and big data technologies. In addition to his studies, Dr. Hsu has mentored numerous students and collaborated on transformative projects that integrate business acumen with cutting-edge information management systems. His educational background continues to influence his impactful research and teaching endeavors.

Experience

Dr. Hsu’s career spans academia, research, and industry collaboration. At Chang Gung University, he has held pivotal roles, including directing advanced programs in IoT, big data, and medical applications. Between 2012 and 2013, he served as a Visiting Professor in the Department of Electrical Engineering and Computer Science at the University of Central Florida (UCF). Dr. Hsu’s leadership includes being a Director of the Chinese Cryptology (CCISA) and Chair of its Membership and Education Promotion Committees. His professional activities also encompass organizing international conferences and symposia, such as the International Security Conference (ISC) and Medical Informatics Symposium in Taiwan. He actively collaborates with Taiwan’s Ministry of Science and Technology, leading cutting-edge research projects in information security and healthcare. His multidisciplinary roles reflect his commitment to integrating technological innovation into societal benefits.

Research Interests

Dr. Chien-Lung Hsu’s research encompasses a wide array of domains, each contributing significantly to the advancement of technology and security. His work in cryptography 🔐 and information security 🛡️ ensures robust mechanisms for safeguarding data across platforms. In mobile commerce 📱 and digital forensics 🔍, he explores innovative solutions to enhance transaction security and forensic investigation methodologies. Dr. Hsu’s focus on healthcare informatics 🏥 integrates secure and efficient data systems to support medical applications. Additionally, his expertise in big data analytics 📊 and the Internet of Things (IoT) 🌐 drives the development of scalable, intelligent, and secure networks for industrial and healthcare use. One of his hallmark contributions is the Taiwan-Japan joint project on lightweight cryptosystems for IoT-based eHealth environments, which emphasizes data integrity and scalability. By adopting an interdisciplinary approach, Dr. Hsu addresses pressing cybersecurity challenges, fostering safer and more reliable digital ecosystems.

Awards and Honors

Dr. Chien-Lung Hsu has received numerous accolades throughout his distinguished career, highlighting his expertise and contributions to the fields of information security and healthcare research. He was honored with the Distinguished Research Award from the Taiwan Ministry of Science and Technology, a testament to his impactful academic and scientific endeavors. Dr. Hsu has also earned multiple Best Paper Awards, including those from eCASE 2010, CISC 2010, JCMIT 2015, and MMHS 2015, showcasing his ability to produce cutting-edge research in highly competitive fields. His dedication and innovation have been further recognized with Research Rewards from Chang Gung University and Chang Gung Memorial Hospital. As a senior member of professional organizations and a certified cybersecurity expert, Dr. Hsu continues to play a pivotal role in advancing Taiwan’s technological landscape. His contributions to academia and industry remain influential and widely celebrated.

Publications

A Hierarchical Blockchain System for Social Economy Services

Authors: Chin, Y.-C.; Hsu, C.-L.; Lin, T.-W.; Tsai, K.-Y.

Year: 2024

Citations: 0

Design and Evaluation of Device Authentication and Secure Communication System with PQC for AIoT Environments

Authors: Chen, Y.-J.; Hsu, C.-L.; Lin, T.-W.; Lee, J.-S.

Year: 2024

Citations: 0

Technological Empowerment for Aging Workforce in Elderly Care Programs: Service Model Design and Development of an Elderly Care Shared Service Platform

Authors: Tsai, T.-H.; Lo, H.-Y.; Wu, S.-L.; Chen, Y.-P.; Hsu, C.-L.

Year: 2024

Citations: 0

ID-Based Deniable Authentication Protocol with Key Agreement and Time-Bound Properties for 6G-Based WBAN Healthcare Environments

Authors: Hsu, C.-L.; Nguyen, A.-T.; Cheng, G.-L.

Year: 2023

Citations: 0

Developing the “Healthcare CEO App” for Patients with Type 1 Diabetes Transitioning from Adolescence to Young Adulthood: A Mixed-Methods Study

Authors: Chiang, Y.-T.; Chang, C.-W.; Yu, H.-Y.; An, C.; Moons, P.

Year: 2023

Citations: 2

BONE+: An AI-Driven Chatbot Platform for Promoting Behavior Change in Bone Health and Osteoporosis Prevention

Authors: Tsai, T.-H.; Hsieh, Y.-S.; Ho, C.-S.; Pei, Y.-C.; Hsu, C.-L.

Year: 2023

Citations: 0

Privacy-Preserved Hierarchical Authentication and Key Agreement for AI-Enabled Telemedicine Systems

Authors: Lin, T.-W.; Hsu, C.-L.

Year: 2023

Citations: 2

A Hybrid Blockchain-Based Log Management Scheme with Nonrepudiation for Smart Grids

Authors: Le, T.-V.; Hsu, C.-L.; Chen, W.-X.

Year: 2022

Citations: 18

Evaluating Digital Divide Based on Big Wireless Logs: A Case Study among Remote Tribes in Taiwan

Authors: Chen, S.-H.; Li, H.-C.; Liaw, Y.-C.; Le, T.-V.; Luo, W.-L.

Year: 2022

Citations: 2

A Novel Three-Factor Authentication Protocol for Multiple Service Providers in 6G-Aided Intelligent Healthcare Systems

Authors: Le, T.-V.; Lu, C.-F.; Hsu, C.-L.; Chou, Y.-F.; Wei, W.-C.

Year: 2022

Citations: 24

Conclusion

Dr. C.L. Hsu is an exceptional candidate for the Best Researcher Award due to his groundbreaking interdisciplinary research, strong leadership roles, and extensive academic contributions. His work on cryptography and information security, particularly its applications in healthcare and IoT, has significant societal and technological implications. While there is potential for greater emphasis on specific contributions and broader community engagement, his current achievements make him a compelling nominee. Recognizing Dr. Hsu would not only honor his accomplishments but also inspire further innovation in critical research areas.

 

Dr. Charles Gaillard | Health Professions | Best Researcher Award

Published on by Academic Achievements

Dr. Charles Gaillard | Health Professions | Best Researcher Award

Dr. Charles Gaillard, Centre Hospitalier Regional et Universitaire de Tours, France

Dr. Charles Gaillard is a dedicated urologist currently completing his medical training with a focus on transplantation and genitourinary oncology. He holds a series of advanced diplomas, including a Diplôme Inter-Universitaire in Oncologie Génito-Urinaire and a Thèse d’Exercice in Medicine, which he defended in 2022 on the topic of renal transplantation and drainage. Dr. Gaillard’s research, particularly his study on the necessity of drainage in renal transplantation, was published in FJUROL in August 2024 and awarded the Silver Medal with Honors from the jury. He has gained extensive clinical experience through internships at leading hospitals in Lyon and Tours, working under prominent professors in urology and vascular surgery.

Professional Profile:

Scopus

Suitability for the Award:

Dr. Gaillard’s research aligns well with the Best Researcher Award, especially given his focus on transplantation, surgical innovation, and urological treatment methodologies. His work contributes both to scientific understanding and practical advances in post-operative patient care, making a meaningful impact in his field.

Academic Background:

Dr. Charles Gaillard earned several prestigious diplomas in his field, including a Diplôme Inter-Universitaire in Genito-Urinary Oncology (2023), Thesis in Medicine on Renal Transplantation (2022), and Diplôme Universitaire in Urinary Lithiasis (2020). He has undergone specialized training in organ transplantation and urology across top institutions such as Sorbonne University and Paris-Lyon-Tours.

Clinical Experience:

Dr. Gaillard’s internship includes comprehensive work at Hôpital Edouard Herriot, Hôpital Bretonneau, and Clinique du Pôle Léonard de Vinci, where he honed his skills in urology, vascular surgery, and renal transplantation under expert supervision.

Research Focus & Achievements:

His doctoral thesis on renal transplantation—titled “Is Redon Drainage Essential in Renal Transplantation?”—was published in FJUROL (2024) and won the Silver Medal with Jury Honors. The study explored risk factors associated with the necessity of drainage in renal transplant surgeries.

Honors & Recognition:

Dr. Gaillard’s dedication to research and clinical excellence has earned him recognition in his field, including Medal of Silver with Jury Congratulations for his groundbreaking research on transplantation.

Publication Top Notes:

  • Cut-off time for surgery and prediction of orchiectomy in spermatic cord torsion: a retrospective multicentric study over 15 years
    • Journal: World Journal of Urology, 2023,
    • Citations: 2
  • Torsion of the spermatic cord in adults: a multicenter experience in adults with surgical exploration for acute scrotal pain with suspected testicular torsion
    • Journal: Asian Journal of Andrology, 2022,
    • Citations: 7
  • TORSAFUF – Surgical exploration for torsion of spermatic cord suspicion and risk factors for unnecessary surgery: Results of a French nationwide retrospective study on 2940 patients
    • Journal: Progres en Urologie, 2022
    • Citations: 2
  • Contralateral Orchiopexy at the Time of Urgent Scrotal Exploration-Is It Safe? A Propensity Score Matched Analysis from the TORSAFUF Cohort
    • Journal: Journal of Urology, 2021
    • Citations: 5

 

 

Yagmur Okcay | Pharnacology, Medical Pharmacology | Best Researcher Award

Published on by Academic Achievements

Ms.Yagmur Okcay | Pharnacology, Medical Pharmacology | Best Researcher Award

PhD Candidate/Research assistant PhD Candidate/Research assistant Turkey

Yağmur Okçay is a dedicated PhD Candidate and Research Assistant at the University of Health Sciences. With a background in pharmacy and a master’s in pharmacology, she is advancing her expertise in medical pharmacology. Her research efforts focus on neuropathic pain, cannabinoids, and behavioral pharmacology, contributing significantly to the field with multiple publications and collaborations.

profile

ORCiD

Education 🎓

Yağmur Okçay completed her undergraduate studies at Anadolu University Faculty of Pharmacy in 2019. She then pursued a master’s degree in Pharmacology. Currently, she is a PhD candidate in Medical Pharmacology at the University of Health Sciences, furthering her academic and research pursuits.

Experience 🏫

In her role as a research assistant at the University of Health Sciences, Yağmur has been actively involved in various research projects and academic endeavors. Her experience spans across multiple areas of pharmacology, where she has contributed to the understanding and development of new therapeutic strategies.

Research Interests 🔬

Yağmur’s research interests are primarily focused on neuropathic pain, behavioral pharmacology, cannabinoids, and the autonomic nervous system pharmacology. Her work aims to elucidate complex biochemical pathways and explore novel therapeutic applications for various pharmacological challenges.

Awards 🏆

Yağmur Okçay’s contributions to pharmacology have been recognized through her active involvement in significant research projects and publications. While specific awards are not mentioned, her nomination for the Best Researcher Award reflects her dedication and impact in the field.

Publications 📄

  1. Dynamic Endocannabinoid-mediated Neuromodulation of Retinal Circadian Circuitry (2024) – Ageing Research Reviews
    • Cited by articles in various pharmacology and neuroscience journals.
  2. Additional publications include 5 research articles and 2 review articles in SCI/SCIE indexed journals, showcasing her extensive research output and scholarly impact.